Pfizer abandons costly hunt for new Alzheimer’s, Parkinson’s drugs

Pfizer Inc. said Saturday it will stop trying to discover new drugs for Alzheimer’s disease and Parkinson’s disease, abandoning costly but futile efforts to find effective treatments for the disorders.